Inspire Medical Systems, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $70.31 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-02-13
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-03-31 was $87.27, a 112.70% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $41.03, a 22.13% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $52.69, a 154.05% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $20.74, a 22.06% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $70.31, a 12.73% increase from fiscal 2024.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $62.37, a 38.32% increase from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $45.09, a 55.48% increase from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $29.00, a 18.17% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-31 | $70.31 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $71.25 10-Q · filed 2025-11-03 | |||
| 2025-06-30 | $73.96 10-Q · filed 2025-08-04 | |||
| 2025-03-31 | $87.27 10-Q · filed 2025-05-05 | |||
| 2024-12-31 | $62.37 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $61.50 10-Q · filed 2024-11-04 | |||
| 2024-06-30 | $53.21 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | $41.03 10-Q · filed 2024-05-07 | |||
| 2023-12-31 | $45.09 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $68.64 10-Q · filed 2023-11-07 | |||
| 2023-06-30 | $71.68 10-Q · filed 2023-08-01 | |||
| 2023-03-31 | $52.69 10-Q · filed 2023-05-02 | |||
| 2022-12-31 | $29.00 10-K · filed 2025-02-10 | |||
| 2022-09-30 | $26.74 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | $22.83 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | $20.74 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | $35.44 10-K · filed 2024-02-09 | |||
| 2021-09-30 | $33.92 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $28.91 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $26.61 10-Q · filed 2021-05-04 | |||
| 2020-12-31 | $11.29 10-K · filed 2023-02-10 | |||
| 2020-09-30 | $7.76 10-Q · filed 2020-11-02 | |||
| 2020-06-30 | $4.67 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | $3.10 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | $1.71 10-K · filed 2022-02-15 | |||
| 2019-09-30 | $1.57 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $1.61 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $1.65 10-Q · filed 2019-05-07 | |||
| 2018-12-31 | $1.86 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $1.90 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $1.80 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | $1.85 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $1.74 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |